EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Novel likely pathogenic MEN1 mosaic mutation in the family with MEN-1 syndrome

Rustam Salimkhanov, Marina Utkina, Hanum Bagirova, Anna Eremkina, Ekaterina Prosandeeva, Sergey Popov, Victoria Zakharova, Vasiliy Petrov, Alexey Novoselov, Ekaterina Bondarenko, Daria Pastukhova, Lyudmila Rozhinskaya und 1 weitere

Frontiers in Endocrinology · 2025

DOI: 10.3389/fendo.2025.1662871 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Endocrinology, 2025. Verfasst von Rustam Salimkhanov und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Moscow, Russia. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 1, Mosaicism, Proto-Oncogene Proteins, Mutation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple endocrine neoplasia type 1 (MEN-1; OMIM 131100) is a rare, autosomal dominant syndrome caused by heterozygous inactivating mutations in the MEN1 tumor suppressor gene (11q13; OMIM 613733). MEN-1 is characterized by polyglandular pathology, which typically involves the parathyroid glands (90%), pancreas (30-80%) and anterior pituitary (15-50%). To date, over 1,600 pathogenic MEN1 variants have been documented, including nonsense, frameshift, and splice-site mutations, as well as rare large deletions. While germline mutation detection rates reach 70-90% in clinically diagnosed probands, approximately 10-30% of phenotypically confirmed MEN-1 families test negative by conventional sequencing, suggesting possible regulatory region defects, deep intronic mutations, or mosaic variants. In cases where MEN1 germline testing is negative despite a clinical MEN-1 phenotype, somatic mosaicism should be considered. We investigated a familial cohort presenting with primary hyperparathyroidism, multifocal pancreatic and pituitary neuroendocrine neoplasms – a triad strongly suggestive of MEN-1. Using a multi-tissue sequencing approach, we analyzed DNA extracted from peripheral blood leukocytes and parathyroid adenomas tissue via both Sanger sequencing and next-generation sequencing (NGS) with high coverage. While conventional Sanger analysis failed to detect a mutation, targeted NGS revealed a novel, likely pathogenic MEN1 variant present at low allele frequency (5-15%), consistent with postzygotic mosaicism. The variant was classified as pathogenic per ACMG/AMP guidelines and correlated with disease manifestations in affected tissues. These findings demonstrate that high-coverage NGS of multiple tissues is critical for identifying low-level mosaic MEN1 mutations missed by standard testing. Alternative screening methods are required for patients with strong clinical indications of MEN-1 and/or a family history, but negative germline test results, one such method is NGS with high coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 1MosaicismProto-Oncogene ProteinsMutationHumansMalePedigreeFemaleAdultMiddle AgedPituitary NeoplasmsGerm-Line MutationPancreatic Neoplasms

Stichwörter der Autor:innen

genetic testinghigh-coverage NGSmosaic mutationmultiple endocrine neoplasia type 1phenocopy

Substanzen

MEN1 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Moscow, Russia.
  • Laboratory of General, Molecular and Population Genetics, Endocrinology Research Centre, Moscow, Russia.
  • Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.
  • Laboratory of Pathomorphology, Endocrinology Research Centre, Moscow, Russia.
  • Department of Osteoporosis and Osteopathies, Endocrinology Research Centre, Moscow, Russia.
  • Directorate, Endocrinology Research Centre, Moscow, Russia.

Zitieren

APA

Salimkhanov, R., Utkina, M., Bagirova, H., Eremkina, A., Prosandeeva, E., Popov, S., Zakharova, V., Petrov, V., Novoselov, A., Bondarenko, E., Pastukhova, D., Rozhinskaya, L., & Mokrysheva, N. (2025). Case Report: Novel likely pathogenic MEN1 mosaic mutation in the family with MEN-1 syndrome. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1662871

Vancouver

Salimkhanov R, Utkina M, Bagirova H, Eremkina A, Prosandeeva E, Popov S, et al. Case Report: Novel likely pathogenic MEN1 mosaic mutation in the family with MEN-1 syndrome. Frontiers in Endocrinology. 2025. doi:10.3389/fendo.2025.1662871

BibTeX
@article{Salimkhanov2025,
  author = {Salimkhanov, Rustam and Utkina, Marina and Bagirova, Hanum and Eremkina, Anna and Prosandeeva, Ekaterina and Popov, Sergey and Zakharova, Victoria and Petrov, Vasiliy and Novoselov, Alexey and Bondarenko, Ekaterina and Pastukhova, Daria and Rozhinskaya, Lyudmila and Mokrysheva, Natalia},
  title = {Case Report: Novel likely pathogenic MEN1 mosaic mutation in the family with MEN-1 syndrome},
  journal = {Frontiers in Endocrinology},
  year = {2025},
  doi = {10.3389/fendo.2025.1662871}
}
Kostenlos starten →